STATCenter·
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
As telehealth promotes GLP-1s for addiction, experts worry about fragmented care, and exposing patients to unknown risks.
Read at STAT →
Health · 1 sources covering this
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
As telehealth promotes GLP-1s for addiction, experts worry about fragmented care, and exposing patients to unknown risks.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/fb75359e1ceb1aa1238e6dba9135bb96f98dc0d5" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction"></iframe>
